24小时热门版块排行榜    

查看: 2263  |  回复: 10
当前只显示满足指定条件的回帖,点击这里查看本话题的所有回帖

PSA

专家顾问 (著名写手)

[交流] NDA for tasocitinib to treat RA 已有5人参与

Pfizer Inc. (NYSEFE), New York, N.Y.
Product: Tofacitinib (CP-690,550) (formerly tasocitinib)
Business: Autoimmune
Molecular target: Janus kinase-3 (JAK-3); Janus kinase-1 (JAK-1)
Description: Oral pan-Janus kinase (JAK) inhibitor
An NDA for tofacitinib to treat rheumatoid arthritis (RA) is
under FDA review with an Aug. 21 PDUFA date, while an MAA is
under review in the EU. The product is also under review in Japan.
In a conference call to discuss its 2Q12 earnings, Pfizer said FDA
requested additional analysis of data in the NDA for tofacitinib,
which the pharma said could cause the agency to extend its review
of the product past its PDUFA date. Specifics about the request
were not disclosed (see BioCentury, Aug. 6). Tofacitinib also is in
Phase III testing to treat moderate to severe plaque psoriasis.
Takeda Pharmaceutical Co. Ltd. (Tokyo:4502, Osaka, Japan) has
rights from Pfizer to co-market tofacitinib in Japan for RA and other
undisclosed indications
回复此楼
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

z1278849487

新虫 (初入文坛)


小木虫: 金币+0.5, 给个红包,谢谢回帖
我想做科研,我们老师给了我这样一个题目:tofacitinib的Me Too药的开发研究,他说tofacitinib是2012年Pfizer上市的重磅新药,是JAK3抑制剂,主治类风湿性关节炎,我们可以对他的分子进行修饰,并合成他的类似物,主要使用一些带有杂原子的环替代现有大的吡啶环,用嘌呤、吲哚等替代其现有的6并5环,得到的类似物进行体外活性测定。

但我一点思路也没有,大家能给我一些建议,谢谢。
9楼2013-02-20 00:04:19
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
查看全部 11 个回答

cpujacs

荣誉版主 (知名作家)

优秀版主优秀版主优秀版主



小木虫: 金币+0.5, 给个红包,谢谢回帖
Takeda Pharmaceutical Co. Ltd. (Tokyo:4502, Osaka, Japan) has rights from Pfizer to co-market tofacitinib in Japan for RA and other undisclosed indications
这种合作是不是将来的一种趋势
3楼2012-08-20 13:15:10
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

PSA

专家顾问 (著名写手)

合作开发,挺好的呵呵!
4楼2012-08-20 13:22:26
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

PSA

专家顾问 (著名写手)

引用回帖:
5楼: Originally posted by 药道人 at 2012-08-20 14:29:39
不看好

你不看好tofacitinib上市?还是不看好合作开发呵呵!
6楼2012-08-20 15:29:08
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
普通表情 高级回复 (可上传附件)
最具人气热帖推荐 [查看全部] 作者 回/看 最后发表
[硕博家园] 售SCI一区文章,我:8.O.551.O.5.4,科目全,可伽急 +3 mibUvS8DDCwf 2026-09-15 3/150 2026-09-17 16:03 by 0ngsZVSCTS7z
[考博] 售SCI文章,我:8O.5.5.1O.54,科目全,可十急 +3 vZfe6xYu34yj 2026-09-14 3/150 2026-09-17 15:29 by 0ngsZVSCTS7z
[硕博家园] 售SCI一区T0P文章,我:8.O.55.1.O54,科目全,可伽急 +5 23jxep3nCNZb 2026-09-14 5/250 2026-09-17 13:53 by ObVzqQQh1rrE
[考研] 售SCI一区文章,我:8O5.5.1.O5.4,科目全,可伽急 +5 23jxep3nCNZb 2026-09-14 5/250 2026-09-17 13:29 by ObVzqQQh1rrE
[找工作] 售SCI一区文章,我:8.O.551.O.5.4,科目全,可伽急 +4 6F5UbRU2I5hL 2026-09-14 4/200 2026-09-17 13:05 by ObVzqQQh1rrE
[硕博家园] 售SCI一区T0P文章,我:8.O.55.1.O.5.4,科目全,可+急 +3 Aj1rhIDL5ixY 2026-09-14 3/150 2026-09-17 05:14 by k06BKNblrGRH
[考研] 售SCI一区T0P文章,我:8.O55.1.O.54,科目全,可十急 +4 Aj1rhIDL5ixY 2026-09-14 4/200 2026-09-17 04:52 by k06BKNblrGRH
[找工作] 售SCI一区文章,我:8.O.55.1.O.54,科目齐全,可伽急 +4 23jxep3nCNZb 2026-09-14 4/200 2026-09-17 04:04 by k06BKNblrGRH
[考研] 售SCI-T0P文章,我:8O.5.5.1.O.54,科目齐全,可+急 +5 6F5UbRU2I5hL 2026-09-14 5/250 2026-09-17 03:14 by Tql5LQhh5rLK
[找工作] 售SCI一区T0P文章,我:8.O.55.1.O.5.4,科目全,可+急 +6 6F5UbRU2I5hL 2026-09-14 6/300 2026-09-17 03:04 by Tql5LQhh5rLK
[考研] 售SCI文章,我:8O5.5.1.O.54,科目齐全,可+急 +7 LwdutQ8HoqWP 2026-09-13 7/350 2026-09-17 01:52 by Tql5LQhh5rLK
[找工作] 售SCI一区T0P文章,我:8.O.55.1.O54,科目全,可伽急 +5 3n8v2C8RimXI 2026-09-13 6/300 2026-09-17 01:50 by Tql5LQhh5rLK
[考研] 售SCI一区文章,我:8.O.55.1.O.54,科目齐全,可伽急 +3 vZfe6xYu34yj 2026-09-14 3/150 2026-09-16 22:26 by Tql5LQhh5rLK
[考研] 售SCI一区T0P文章,我:8.O.55.1.O.5.4,科目全,可+急 +4 s3fFTmArrBt6 2026-09-13 6/300 2026-09-16 16:00 by i3KBRD19ERkG
[考博] 上海工程技术大学激光智能制造课题组招收博士研究生 +8 两三岁ss 2026-09-14 8/400 2026-09-16 09:46 by 水士口
[硕博家园] 售SCI一区文章,我:8.O.551.O.5.4,科目全,可伽急 +4 s3fFTmArrBt6 2026-09-13 6/300 2026-09-16 03:50 by DgNGHc3h5tPl
[考研] 售SCI一区T0P文章,我:8.O.55.1.O.5.4,科目全,可+急 +5 LwdutQ8HoqWP 2026-09-13 5/250 2026-09-16 03:14 by DgNGHc3h5tPl
[找工作] 售SCI一区T0P文章,我:8.O.55.1.O.5.4,科目全,可+急 +7 QUjhNVAcOSff 2026-09-13 8/400 2026-09-16 02:23 by DgNGHc3h5tPl
[公派出国] 售SCI一区T0P文章,我:8O.55.1.O.5.4,科目齐全,可+急 +4 3n8v2C8RimXI 2026-09-13 5/250 2026-09-15 14:58 by CgyNCDVNhGVg
[教师之家] 售SCI一区T0P文章,我:8O.55.1.O.54,科目全,可伽急 +4 6F5UbRU2I5hL 2026-09-14 4/200 2026-09-15 07:50 by C79jjtjAKjEn
信息提示
请填处理意见